 BARCELONA, Spain, Jan. 18, 2021 PRNewswire -- Grifols MCE: GRF, MCE: GRF.P, NASDAQ: GRFS, a global leader in the development of therapies with plasma-derived proteins with a track record of more than 100 years dedicated to enhancing peoples health and well-being, today announced it... 